Wei Wang

Wei Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2023 in Frontiers in Surgery
Verified
Journal Article
Open access
CWCheng-Qian Wang
Cheng-Qian Wang
JWJie Wang
Jie Wang
FLFei-Yu Liu
Fei-Yu Liu
WWWei Wang
Wei Wang
Introduction: Surgeons have widely regarded sternotomy (ST) as the standard surgical method for thymectomy. Minimally invasive methods for thymectomy, including video-assisted and robot-assisted thoracoscopic surgery (RATS), have been explored. There are some studies have researched and compared the outcomes of patients after robotic and sternotomy procedure.Methods: We searched the databases of Pubmed, the Cochrane Library, Embase and selected the studies on the efficacy and safety of RATS or ST for thymectomy. Meta-analysis was performed for operation time, operation blood loss, postoperative drainage time, operative complications and hospitalization time.Results: A total of 16 cohort studies with 1,089 patients were included. Compared to ST, RATS is an appropriate alternative for thymectomy which reduced operation blood loss [standardized mean difference (SMD) = −1.82, 95% confidence interval (95% CI): (−2.64, −0.99), p = 0.000], postoperative drainage time [SMD = −2.47, 95% Cl: (−3.45, −1.48), p = 0.000], operative complications [odds ratio (OR) = 0.31, 95% Cl: (0.18, 0.51), p = 0.000] and hospitalization time [SMD = −1.62, 95% Cl: (−2.16, −1.07), p = 0.000].Conclusions: This meta-analysis based on cohort studies shows that RATS has more advantages over ST. Therefore, RATS is a more advanced and suitable surgical method for thymectomy.

29 July 2025 in Tissue and Cell
Verified
Journal Article
Closed access
SWShuang Wu
Shuang Wu
FLFeiyu Liu
Feiyu Liu
XYXiangwen Yao
Xiangwen Yao
YLYiming Lei
Yiming Lei
WWWei Wang
Wei Wang

7 October 2022 in Medicine
Verified
Journal Article
Open access
CWCheng-Qian Mm Wang
Cheng-Qian Mm Wang
FLFeiyu Liu
Feiyu Liu
WWWei Wang
Wei Wang
Introduction: Lobaplatin is a new platinum-based cytotoxic chemotherapeutic agent. Endostar is an endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate the efficacy and safety of thoracic perfusion of lobaplatin combined with endostar in the treatment of malignant pleural effusions (MPE). Methods: We searched the databases of Pubmed, the Cochrane Library, Embase, WanFang Data, and CNKI to select the studies regarding the efficacy and safety of lobaplatin combined with endostar to treat MPE. A total of 10[3–12] randomized controlled trials with 651 patients were included. Results: The objective response rate (P < .001, odds ratio = 4.08) and disease control rate (P < .001, odds ratio = 3.69) of lobaplatin combined with endostar were significantly higher than lobaplatin alone. In addition, lobaplatin combined with endostar remarkably promoted the quality of life of patients (P < .001, odds ratio = 3.93) compared with lobaplatin alone. Lobaplatin combined with endostar also promoted the quality of life of patients (P < .05, odds ratio = 2.56) compared with cisplatin combined with endostar. At the same time, the leukopenia rate (P < .05, odds ratio = .40) and the incidence of nausea and vomiting (P < .05, odds ratio = .38) of lobaplatin combined with endostar were significantly lower than that of cisplatin combined with endostar. Conclusions: The efficacy of lobaplatin combined with endostar was superior to lobaplatin alone. The safety was higher than cisplatin combined with endostar through thoracic perfusion in treating MPE, which indicated that lobaplatin combined with endostar could be the effective agent for controlling MPE.

4 June 2026 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
YLYiming Lei
Yiming Lei
SSShengteng Shao
Shengteng Shao
TJTingshu Jiang
Tingshu Jiang
WWWei Wang
Wei Wang
Objective: To investigate the clinical characteristics, diagnostic challenges, and management strategies of long-term retained sharp intrapulmonary foreign bodies and to improve clinicians’ understanding of this rare condition. Methods: We report a case of a 54-year-old male patient presenting with hemoptysis. The diagnosis was established through imaging, multidisciplinary consultation, thoracoscopic surgery, and pathological examination. Additionally, the relevant literature was reviewed to summarize the clinical features of such cases. Results: Chest CT revealed a dense shadow in the left lower lobe. Following multidisciplinary consultation, a diagnosis of “sharp intrapulmonary foreign body complicated by infection” was made. The patient underwent thoracoscopic left lower lobectomy, during which three nail-like foreign bodies, approximately 1.0–2.0 cm in length, were successfully removed. Postoperative pathology confirmed foreign body-induced pulmonary infection. Further history-taking suggested that the foreign bodies were likely the result of an accidental nail gun injury sustained in a workshop approximately 10 years prior. Conclusion: Chronic intrapulmonary sharp foreign bodies may remain clinically silent for extended periods, posing diagnostic challenges. A high index of suspicion combined with detailed imaging is essential for diagnosis. Management should be individualized, with surgical intervention considered in symptomatic patients or when complications are likely. For completely asymptomatic patients with a stable foreign body position and no evidence of complications, conservative management with regular imaging follow-up may be a reasonable alternative.

1 May 2026 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
YLYiming Lei
Yiming Lei
XZXingbo Zhang
Xingbo Zhang
WHWeiran Hou
Weiran Hou
XZXiumin Zhang
Xiumin Zhang
ZZZirui Zhou
Zirui Zhou
ZWZhen Wang
Zhen Wang
Background: Esophageal squamous cell carcinoma (ESCC) is a major malignancy of the upper gastrointestinal tract. Owing to limited actionable therapeutic targets, long-term outcomes remain unsatisfactory. This study aimed to investigate the prognostic value of non-myelinating Schwann cells (nmSCs) infiltration in ESCC and to identify potential upstream regulators and underlying mechanisms. Methods: nmSCs infiltration was quantified in ESCC transcriptomic datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) using single-sample gene set enrichment analysis (ssGSEA). Genes associated with nmSC infiltration were identified by weighted gene co-expression network analysis (WGCNA) and correlation analyses. Potential upstream regulators and signaling pathways were explored by pan-cancer analyses in the Tumor Immune Estimation Resource (TIMER) database. nmSCs infiltration and candidate regulator expression were validated in an independent surgical cohort by immunohistochemistry (IHC). In addition, to investigate the regulatory relationship between teashirt zinc finger homeobox 3 (TSHZ3) and neuregulin 1 (NRG1) and their effects on Schwann cells (SCs) function, a co-culture system of ESCC cells and SCs was established. Functional validation was performed by knocking down TSHZ3 in ESCC cells, followed by quantitative real-time polymerase chain reaction (qRT-PCR), Western blot, and Cell Counting Kit-8 (CCK-8) assays. A postoperative prognostic model incorporating nmSC infiltration was subsequently developed. Results: Elevated nmSCs infiltration was significantly associated with poor survival in ESCC. IHC validation further confirmed nmSCs infiltration as an independent prognostic risk factor in patients undergoing surgical resection. Integrated analyses identified TSHZ3 as a potential upstream regulator of SCs infiltration, potentially acting through the NRG1 pathway in ESCC and multiple other tumor types. IHC demonstrated a significant positive correlation between TSHZ3 expression and nmSCs infiltration. Further in vitro functional experiments confirmed that knockdown of TSHZ3 in ESCC cells significantly reduced NRG1 expression levels and inhibited the proliferative capacity of SCs in the co-culture system, providing more direct evidence for the TSHZ3-NRG1 regulatory axis. Conclusions: nmSCs infiltration predicts adverse prognosis in ESCC, and TSHZ3 may promote nmSCs infiltration via the NRG1 signaling axis.